Slug:opella-mexico-enterogermina-investment Opella has invested $70 million in a new Enterogermina [...]
EnteroBiotix has dosed the first patient in its Phase 2b [...]
Researchers in Singapore have developed a fluorescent nanosensor capable of [...]
MaaT Pharma has randomized the first patient in the IMMUNOLIFE [...]
Bringing you the latest industry news and insights every day
Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596
© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design
